[go: up one dir, main page]

PE20050479A1 - Preparacion farmaceutica solida - Google Patents

Preparacion farmaceutica solida

Info

Publication number
PE20050479A1
PE20050479A1 PE2004001120A PE2004001120A PE20050479A1 PE 20050479 A1 PE20050479 A1 PE 20050479A1 PE 2004001120 A PE2004001120 A PE 2004001120A PE 2004001120 A PE2004001120 A PE 2004001120A PE 20050479 A1 PE20050479 A1 PE 20050479A1
Authority
PE
Peru
Prior art keywords
pharmaceutical preparation
solid pharmaceutical
richulthane
dyspane
solid
Prior art date
Application number
PE2004001120A
Other languages
English (en)
Inventor
Ulrich Brauns
Thomas Friedl
Sabine Landerer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10353832A external-priority patent/DE10353832A1/de
Priority claimed from DE102004012045A external-priority patent/DE102004012045A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20050479A1 publication Critical patent/PE20050479A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

REFERIDA A UNA PREPARACION FARMACEUTICA SOLIDA QUE CONTIENE UNO O VARIOS VEHICULOS Y/O COADYUVANTES SOLIDOS Y UN PRINCIPIO ACTIVO DEL GRUPO DE LOS INHIBIDORES DE LA REABSORCION DE NEUROTRANSMISORES MONOAMINICOS CUYA ESTRUCTURA ES TROPANO 2,3-DISUSTITUIDA DE FORMULA I DONDE R ES H, ALQUILO, ALQUENILO, ENTRE OTROS; R3 ES PIRIDILO, TIENILO, BENCILO, ENTRE OTROS; R4 ES FENILO, 3,4-METILENDIOXIFENILO, NAFTILO, ENTRE OTROS. TAMBIEN REFERIDA A LA PREPARACION QUE COMPRENDE ESTOS COMPUESTOS QUE SON UTILES EN LA PREVENCION Y TRATAMIENTO DE TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL, DEPRESION, DEMENCIA, OBESIDAD, ENTRE OTROS
PE2004001120A 2003-11-18 2004-11-16 Preparacion farmaceutica solida PE20050479A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10353832A DE10353832A1 (de) 2003-11-18 2003-11-18 Feste pharmazeutische Zubereitungsform
DE102004012045A DE102004012045A1 (de) 2004-03-11 2004-03-11 Feste pharmazeutische Zubereitungsform

Publications (1)

Publication Number Publication Date
PE20050479A1 true PE20050479A1 (es) 2005-10-06

Family

ID=34621295

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004001120A PE20050479A1 (es) 2003-11-18 2004-11-16 Preparacion farmaceutica solida

Country Status (17)

Country Link
US (2) US20050124651A1 (es)
EP (1) EP1686965A2 (es)
JP (2) JP2007511559A (es)
KR (1) KR20060125805A (es)
AR (1) AR046709A1 (es)
AU (1) AU2004290520A1 (es)
BR (1) BRPI0416691A (es)
CA (1) CA2545513C (es)
CO (1) CO5690555A2 (es)
IL (1) IL175246A0 (es)
MX (1) MXPA06005545A (es)
NO (1) NO20062810L (es)
NZ (1) NZ547880A (es)
PE (1) PE20050479A1 (es)
RU (1) RU2377987C2 (es)
TW (1) TW200529844A (es)
WO (1) WO2005049024A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1686965A2 (de) * 2003-11-18 2006-08-09 Boehringer Ingelheim International GmbH Feste pharmazeutische zubereitungsform
WO2007028769A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for neuroprotection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227524A (ja) * 1985-03-30 1986-10-09 Tooa Eiyoo Kk プラゾシン製剤及びその製法
WO1987004077A1 (en) * 1986-01-03 1987-07-16 The University Of Melbourne Gastro-oesophageal reflux composition
JPS62221626A (ja) * 1986-03-20 1987-09-29 Tokyo Tanabe Co Ltd １，４−ジヒドロピリジン化合物の製剤用組成物
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
JPH07118154A (ja) * 1993-10-22 1995-05-09 Dainippon Pharmaceut Co Ltd 固体分散体および粒状製剤
ZA971525B (en) * 1996-02-22 1997-10-21 Neurosearch As Tropane derivatives, their preparation and use.
FR2762316B1 (fr) * 1997-04-18 1999-12-17 Sanofi Synthelabo Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
DE60025750T2 (de) * 1999-11-11 2006-10-19 Kyorin Pharmaceutical Co., Ltd. Orale feste zusammensetzung
CA2401569C (en) * 2000-02-29 2009-08-18 Bristol-Myers Squibb Company Low dose entecavir formulation and use
KR100381834B1 (ko) * 2000-05-20 2003-04-26 이상득 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법
US20040106643A1 (en) * 2001-05-23 2004-06-03 Gouliaev Alex Haarh Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP2005511639A (ja) * 2001-11-30 2005-04-28 ニューロサーチ、アクティーゼルスカブ 虚血性疾患の治療用ドパミン再取り込み阻害活性を有するトロパン誘導体
ATE536874T1 (de) * 2002-05-30 2011-12-15 Neurosearch As Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
ATE519486T1 (de) * 2003-10-16 2011-08-15 Neurosearch As Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
EP1686965A2 (de) * 2003-11-18 2006-08-09 Boehringer Ingelheim International GmbH Feste pharmazeutische zubereitungsform
CA2554617A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist

Also Published As

Publication number Publication date
AR046709A1 (es) 2005-12-21
IL175246A0 (en) 2006-10-31
KR20060125805A (ko) 2006-12-06
US20050124651A1 (en) 2005-06-09
RU2006121446A (ru) 2008-01-10
JP2007511559A (ja) 2007-05-10
WO2005049024A2 (de) 2005-06-02
WO2005049024A3 (de) 2006-03-30
JP2011068690A (ja) 2011-04-07
NO20062810L (no) 2006-08-10
NZ547880A (en) 2010-02-26
CO5690555A2 (es) 2006-10-31
HK1094676A1 (zh) 2007-04-04
BRPI0416691A (pt) 2007-01-30
MXPA06005545A (es) 2006-08-17
CA2545513A1 (en) 2005-06-02
US20100178342A1 (en) 2010-07-15
EP1686965A2 (de) 2006-08-09
RU2377987C2 (ru) 2010-01-10
CA2545513C (en) 2013-01-08
TW200529844A (en) 2005-09-16
AU2004290520A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
DE60132975D1 (de) Neue substanzen und verbindungen als protease-inhibitoren
ATE397602T1 (de) 9-(piperazinylalkyl)carbazole als bax-modulatoren
NO20062677L (no) Benzyleteraminforbindelser anvendbare som CCR-5-antagonister
PE20071136A1 (es) Derivados de anilina sustituida como antagonistas de la histamina h3
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
NI200700270A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
ATE395392T1 (de) Bimesogene verbindungen und flexoelektrische vorrichtungen
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
ATE478664T1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
DE60322877D1 (de) Tetrahydropyranylcyclopentyltetrahydroisochino-linmodulatoren der chemokinrezeptoraktivität
DE60236206D1 (de) Spiroazacyclische verbindungen als monoaminrezeptormodulatoren
HUP0401740A2 (hu) N-szubsztituált hidroxipirimidinon-karboxamid HIV-integráz inhibitorok és ezeket tartalmazó gyógyszerkészítmények
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
PE41796A1 (es) Compuesto activo en el receptor de serotonina 5-ht, util en el tratamiento de enfermedades del s.n.c.
DK0941095T3 (da) Forbedrede farmaceutiske sammensætninger
NO20063355L (no) Nye trisykliske spiroderivater som modulatorer for kemokinreseptoraktivitet
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
DK1517890T3 (da) Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
AR028705A1 (es) Bis-arilsulfonas
ATE478048T1 (de) Pharmazeutisch aktive benzsulfonamidderivate als inhibitoren von protein-jun-kinasen
ATE383337T1 (de) 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1- phenylpropan-2-olderivate und verwandte verbindungen als modulatoren der norepinephrin- (ne-) und der serotonin-(5-ht-) aktivität und der monoaminwiederaufnahme zur behandlung von vasomotorischen symptomen (vms)
ATE355054T1 (de) Verfahren und verbindungen zur behandlung der depression
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
PE20050479A1 (es) Preparacion farmaceutica solida
AR046295A1 (es) Abridor de canal k activado por calcio de alta conductancia

Legal Events

Date Code Title Description
FC Refusal